Results 181 to 190 of about 39,541 (234)

Breakthroughs in women's health for treating vasomotor symptoms

Taiwanese Journal of Obstetrics & Gynecology
Peng-Hui Wang, Wen-Ling Lee
doaj   +1 more source

Revolutionizing menopause management: Nonhormonal therapy for vasomotor symptoms

Health Sciences Review
Shanzey Rai, Natalia Aslam Khan
doaj   +1 more source

Lifestyle Medicine and Vasomotor Symptoms: An Analytic Review. [PDF]

Am J Lifestyle Med
Kennard A, Lindo FM, Ring M, Alli B, Khan N, Potter-McQuilkin D, Papia G, Teng R, McKendree R, Thompson-Olson M, Tollefson M.   +10 more
europepmc   +1 more source

Exit Interviews Examining Changes to Mood and Work/Productivity Impacts Related to Vasomotor Symptoms: Perspectives of Postmenopausal Women Receiving Elinzanetant in Phase III Clinical Trials. [PDF]

Patient
Haberland C, Barclay M, Lehane A, Whyman S, Gater A, Wikstrom H, Seitz C, Schoof N, Schoof N, Trigg A, Bradley H.   +10 more
europepmc   +1 more source

Nonhormonal Pharmacotherapies for the Treatment of Postmenopausal Vasomotor Symptoms. [PDF]

Cureus
Witten T, Staszkiewicz J, Gold L, Granier MA, Klapper RJ, Lavespere G, Dorius B, Allampalli V, Ahmadzadeh S, Shekoohi S, Kaye AD, Varrassi G.   +11 more
europepmc   +1 more source

Menopausal vasomotor symptoms and plasma Alzheimer disease biomarkers. [PDF]

Am J Obstet Gynecol
Thurston RC, Maki P, Chang Y, Wu M, Aizenstein HJ, Derby CA, Karikari TK.   +6 more
europepmc   +1 more source

Response to: Letter to the Editor Regarding: Safety of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies. [PDF]

Adv Ther
Kagan R, Cano A, Nappi RE, English ML, Mancuso S, Wu X, Ottery FD.   +6 more
europepmc   +1 more source

Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.

JAMA
Pinkerton JV, Simon JA, Joffe H, Maki PM, Nappi RE, Panay N, Soares CN, Thurston RC, Caetano C, Haberland C, Haseli Mashhadi N, Krahn U, Mellinger U, Parke S, Seitz C, Zuurman L.   +15 more
europepmc   +1 more source